NASDAQ: WAYWaystar Holding Corp Stock
$34.35-1.05 (-2.97%)
Updated Dec 5, 2025
WAY Price
$34.35
Fair Value Price
$21.33
Market Cap
$6.57B
52 Week Low
$30.75
52 Week High
$48.11
P/E
50.51x
P/B
2.04x
P/S
6.36x
PEG
1.29x
Dividend Yield
N/A
Revenue
$1.04B
Earnings
$111.18M
Gross Margin
67.8%
Operating Margin
23.41%
Profit Margin
10.7%
Debt to Equity
0.47
Operating Cash Flow
$308M
Beta
0.84
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
WAY Overview
Waystar Holding Corp. develops a cloud-based software solution for healthcare payments. Its platform offers financial clearance, patient financial care, claim and payment management, denial prevention and recovery, revenue capture, and analytics and reporting solutions. The company primarily serves healthcare industry. Waystar Holding Corp. was founded in 2017 and is based in Lehi, Utah.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine WAY's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
B
WAY
Ranked#22 of 45
Ranked#22 of 45
Be the first to know about important WAY news, forecast changes, insider trades & much more!
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how WAY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
WAY ($34.35) is overvalued by 61.01% relative to our estimate of its Fair Value price of $21.33 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
WAY ($34.35) is not significantly undervalued (61.01%) relative to our estimate of its Fair Value price of $21.33 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
WAY ($34.35) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more WAY due diligence checks available for Premium users.
Valuation
WAY fair value
Fair Value of WAY stock based on Discounted Cash Flow (DCF)
Price
$34.35
Fair Value
$21.33
Overvalued by
61.01%
WAY ($34.35) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
WAY ($34.35) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
WAY ($34.35) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
WAY price to earnings (PE)
For valuing profitable companies with steady earnings
Company
50.51x
Industry
46.68x
Market
46.7x
WAY is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
WAY is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
WAY price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.04x
Industry
4.13x
WAY is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
WAY price to earnings growth (PEG)
For valuing profitable companies with growth potential
WAY is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
WAY's financial health
Profit margin
Revenue
$268.7M
Net Income
$30.6M
Profit Margin
11.4%
WAY's Earnings (EBIT) of $243.43M... subscribe to Premium to read more.
Interest Coverage Financials
WAY's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$4.7B
Liabilities
$1.5B
Debt to equity
0.47
WAY's short-term assets ($613.58M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
WAY's long-term liabilities ($1.37B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
WAY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$82.0M
Investing
$44.6M
Financing
$7.2M
WAY's operating cash flow ($307.81M)... subscribe to Premium to read more.
Debt Coverage Financials
WAY vs Health Information Service Stocks
Waystar Holding Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.